Ratings by Goldman Sachs (Salveen Richter)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/23/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Agios Pharma | AGIO | Upgrade | Neutral (Buy) |
28.41 (29.19) |
2.75% | Details | |
| 11/15/2022 | 4D Molecular Therapeutics | FDMT | Upgrade | Buy (Neutral) |
13.49 (21.29) |
57.82% | Details | |
| 11/14/2022 | Prime Medicine | PRME | New Coverage | Neutral (N/A) |
20.57 (16.97) |
-17.5% | Details | |
| 11/11/2022 | Lyell Immunopharma | LYEL | Downgrade | Neutral (Buy) |
4.96 (3.27) |
-34.07% | Details | |
| 11/10/2022 | Kronos Bio Inc. | KRON | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/9/2022 | Taysha Gene Therapies | TSHA | Downgrade | Neutral (Buy) |
2.20 (1.54) |
-30% | Details | |
| 11/9/2022 | Recursion Pharmaceuticals | RXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/4/2022 | Acadia Pharmaceuticals | ACAD | Downgrade | Sell (Neutral) |
15.93 (18.53) |
16.32% | Details | |
| 11/3/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Sana Biotechnology | SANA | Maintain | Neutral (N/A) |
|
Details | ||
| 11/3/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2022 | Vertex | VRTX | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 10/28/2022 | Alnylam Pharmaceuticals | ALNY | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2022 | Biogen | BIIB | Upgrade | Buy (Neutral) |
273.56 (285.94) |
4.53% | Details | |
| 10/13/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | bluebird bio | BLUE | Maintain | Sell (N/A) |
|
Details | ||
| 9/8/2022 | Regeneron Pharma | REGN | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2022 | bluebird bio | BLUE | Maintain | Sell (N/A) |
|
Details | ||
| 8/12/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2022 | Recursion Pharmaceuticals | RXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
71.70 (40.12) |
-44.04% | Details | |
| 7/29/2022 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2022 | Allogene | ALLO | Upgrade | Buy (Neutral) |
12.24 (7.67) |
-37.34% | Details | |
| 6/21/2022 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/2/2022 | 2Seventy Bio Inc. | TSVT | New Coverage | Buy (N/A) |
14.25 (12.84) |
-9.89% | Details | |
| 4/13/2022 | Amicus Therapeutics | FOLD | New Coverage | Neutral (N/A) |
8.38 (12.75) |
52.15% | Details | |
| 3/31/2022 | Vertex | VRTX | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 2/25/2022 | Ionis Pharmaceuticals | IONS | Maintain | Sell (N/A) |
|
Details | ||
| 2/25/2022 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Relay Therapeutics | RLAY | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2022 | Allogene | ALLO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/17/2022 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/16/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 12/20/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2021 | Reata Pharmaceuticals | RETA | Downgrade | Neutral (Buy) |
54.42 (37.09) |
-31.84% | Details | |
| 12/7/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2021 | Regeneron Pharma | REGN | New Coverage | Buy (N/A) |
628.73 (736.46) |
17.13% | Details | |
| 12/6/2021 | Amgen | AMGN | New Coverage | Buy (N/A) |
202.44 (251.59) |
24.28% | Details | |
| 12/6/2021 | Gilead Sciences | GILD | New Coverage | Neutral (N/A) |
69.56 (83.35) |
19.82% | Details | |
| 12/6/2021 | Biogen | BIIB | New Coverage | Neutral (N/A) |
223.92 (285.94) |
27.7% | Details | |
| 11/24/2021 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2021 | Alnylam Pharmaceuticals | ALNY | Upgrade | Buy (Neutral) |
181.00 (225.40) |
24.53% | Details | |
| 11/8/2021 | bluebird bio | BLUE | Downgrade | Sell (Neutral) |
13.14 (6.11) |
-53.5% | Details | |
| 11/5/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2021 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 10/7/2021 | Allogene | ALLO | Downgrade | Neutral (Buy) |
23.97 (7.67) |
-68% | Details | |
| 9/21/2021 | Seagen | SGEN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/24/2021 | Omega Therapeutics | OMGA | New Coverage | Neutral (N/A) |
21.83 (7.70) |
-64.73% | Details | |
| 8/20/2021 | Intercept Pharmaceuticals | ICPT | Downgrade | Sell (Neutral) |
14.22 (17.94) |
26.16% | Details | |
| 8/10/2021 | bluebird bio | BLUE | Downgrade | Neutral (Buy) |
18.16 (13.14) |
-27.64% | Details | |
| 8/6/2021 | Sana Biotechnology | SANA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/6/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2021 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2021 | Agios Pharma | AGIO | Downgrade | Sell (Neutral) |
49.84 (29.19) |
-41.43% | Details | |
| 7/29/2021 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/12/2021 | Lyell Immunopharma | LYEL | New Coverage | Buy (N/A) |
15.25 (3.27) |
-78.56% | Details | |
| 6/24/2021 | TCR2 Therapeutics | TCRR | New Coverage | Buy (N/A) |
17.24 (1.40) |
-91.88% | Details | |
| 6/22/2021 | Centessa Pharmaceuticals | CNTA | New Coverage | Buy (N/A) |
24.91 (3.81) |
-84.7% | Details | |
| 5/24/2021 | Reata Pharmaceuticals | RETA | New Coverage | Buy (N/A) |
111.60 (54.42) |
-51.24% | Details | |
| 5/20/2021 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/14/2021 | 4D Molecular Therapeutics | FDMT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/11/2021 | Recursion Pharmaceuticals | RXRX | New Coverage | Neutral (N/A) |
27.73 (8.06) |
-70.93% | Details | |
| 5/10/2021 | Amicus Therapeutics | FOLD | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2021 | Incyte | INCY | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2021 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2021 | Agios Pharma | AGIO | New Coverage | Neutral (N/A) |
55.78 (49.84) |
-10.65% | Details | |
| 4/29/2021 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/6/2021 | Acadia Pharmaceuticals | ACAD | Downgrade | Neutral (Buy) |
25.59 (18.53) |
-27.59% | Details | |
| 3/28/2021 | 4D Molecular Therapeutics | FDMT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/25/2021 | Sana Biotechnology | SANA | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/18/2021 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2021 | Taysha Gene Therapies | TSHA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2021 | Passage Bio Inc. | PASG | Upgrade | Buy (Neutral) |
19.59 (1.43) |
-92.7% | Details | |
| 3/3/2021 | Adeptus Biotechnologies Corp. | ADPT | Downgrade | Neutral (Buy) |
53.11 (9.01) |
-83.04% | Details | |
| 3/2/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2021 | uniQure BV | QURE | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2021 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/1/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (Buy) |
|
Details | ||
| 3/1/2021 | Sana Biotechnology | SANA | New Coverage | Neutral (N/A) |
32.05 (4.65) |
-85.49% | Details | |
| 2/26/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (Buy) |
|
Details | ||
| 2/26/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | Acadia Pharmaceuticals | ACAD | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2021 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/17/2020 | Intellia Therapeutics | NTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Cellectis | CLLS | Maintain | Sell (N/A) |
|
Details | ||
| 11/6/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 10/19/2020 | Taysha Gene Therapies | TSHA | New Coverage | Neutral (N/A) |
21.05 (1.54) |
-92.68% | Details | |
| 10/16/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 9/21/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2020 | Intellia Therapeutics | NTLA | New Coverage | Buy (N/A) |
22.45 (40.12) |
78.71% | Details | |
| 9/8/2020 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 8/20/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/19/2020 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 8/13/2020 | Precision BioSciences Inc. | DTIL | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2020 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Relay Therapeutics | RLAY | New Coverage | Buy (N/A) |
41.02 (20.95) |
-48.93% | Details | |
| 8/6/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2020 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
77.49 (17.94) |
-76.85% | Details | |
| 6/25/2020 | Passage Bio Inc. | PASG | Downgrade | Neutral (Buy) |
36.07 (1.43) |
-96.04% | Details | |
| 6/3/2020 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Buy (N/A) |
39.07 (9.01) |
-76.94% | Details | |
| 6/1/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2020 | Allogene | ALLO | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | Incyte | INCY | Downgrade | Buy (Conviction Buy) |
99.37 (83.65) |
-15.82% | Details | |
| 5/26/2020 | Seattle Genetics | SGEN | Upgrade | Conviction Buy (Buy) |
155.77 (139.98) |
-10.14% | Details | |
| 5/18/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2020 | Arrowhead Research | ARWR | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2020 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2020 | Madrigal Pharmaceuticals | MDGL | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2020 | Mirati Therapeutics | MRTX | New Coverage | Buy (N/A) |
85.32 (51.81) |
-39.28% | Details | |
| 4/3/2020 | Precision BioSciences Inc. | DTIL | Downgrade | Neutral (Buy) |
5.27 (1.14) |
-78.37% | Details | |
| 3/31/2020 | Acadia Pharmaceuticals | ACAD | Upgrade | Buy (Neutral) |
38.83 (25.59) |
-34.1% | Details | |
| 3/26/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2020 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2020 | Arrowhead Research | ARWR | New Coverage | Neutral (N/A) |
26.32 (33.28) |
26.44% | Details | |
| 3/6/2020 | Cellectis | CLLS | Downgrade | Sell (Neutral) |
15.74 (3.01) |
-80.88% | Details | |
| 2/28/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Sage Therapeutics | SAGE | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2020 | Moderna | MRNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/14/2020 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 2/13/2020 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 2/11/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2020 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 1/27/2020 | Denali Therapeutics Inc. | DNLI | Upgrade | Buy (Neutral) |
24.90 (30.11) |
20.92% | Details | |
| 1/3/2020 | Incyte | INCY | Maintain | Conviction Buy (N/A) |
|
Details | ||
| 12/24/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2019 | uniQure BV | QURE | New Coverage | Buy (N/A) |
54.78 (20.64) |
-62.32% | Details | |
| 11/21/2019 | Alnylam Pharmaceuticals | ALNY | Maintain | Neutral (N/A) |
|
Details | ||
| 11/19/2019 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/18/2019 | Karuna Therapeutics Inc. | KRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Solid Biosciences | SLDB | Maintain | Sell (N/A) |
|
Details | ||
| 11/11/2019 | Cellectis | CLLS | Maintain | Neutral (N/A) |
|
Details | ||
| 10/23/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2019 | Agios Pharma | AGIO | Maintain | Neutral (N/A) |
|
Details | ||
| 10/21/2019 | Acorda Therapeutics, Inc. | ACOR | Maintain | Sell (N/A) |
|
Details | ||
| 9/27/2019 | Atara Biotherapeutics | ATRA | Downgrade | Sell (Neutral) |
14.29 (4.89) |
-65.78% | Details | |
| 9/27/2019 | Seattle Genetics | SGEN | Upgrade | Buy (Conviction Sell) |
73.62 (155.77) |
111.59% | Details | |
| 9/3/2019 | Vertex | VRTX | Upgrade | Conviction Buy (Buy) |
180.02 (319.98) |
77.75% | Details | |
| 8/20/2019 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Cellectis | CLLS | Maintain | Neutral (N/A) |
|
Details | ||
| 7/23/2019 | Karuna Therapeutics Inc. | KRTX | New Coverage | Buy (N/A) |
19.69 (195.00) |
890.35% | Details | |
| 5/28/2019 | BioMarin Pharmaceutical Inc. | BMRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2019 | Alexion Pharmaceuticals | ALXN | New Coverage | Neutral (N/A) |
128.80 (182.01) |
41.31% | Details | |
| 5/23/2019 | Vertex | VRTX | New Coverage | Buy (N/A) |
169.12 (180.02) |
6.45% | Details | |
| 5/23/2019 | Alnylam Pharmaceuticals | ALNY | New Coverage | Neutral (N/A) |
67.87 (225.40) |
232.11% | Details | |
| 5/23/2019 | Agios Pharma | AGIO | New Coverage | Neutral (N/A) |
51.36 (29.19) |
-43.17% | Details | |
| 5/23/2019 | Blueprint Medicines | BPMC | New Coverage | Buy (N/A) |
78.97 (46.71) |
-40.85% | Details | |
| 5/14/2019 | Solid Biosciences | SLDB | Downgrade | Sell (Neutral) |
8.85 (7.56) |
-14.58% | Details | |
| 5/7/2019 | GW Pharma | GWPH | Maintain | Buy (N/A) |
|
Details | ||
| 4/22/2019 | Precision BioSciences Inc. | DTIL | New Coverage | Buy (N/A) |
12.18 (5.27) |
-56.73% | Details | |
| 1/28/2019 | CRISPR Therapeutics | CRSP | Downgrade | Neutral (Buy) |
32.29 (49.96) |
54.72% | Details | |
| 1/15/2019 | Incyte | INCY | Upgrade | Conviction Buy (Buy) |
74.65 (99.37) |
33.11% | Details | |
| 1/2/2019 | Moderna | MRNA | New Coverage | Buy (N/A) |
15.27 (180.87) |
1084.48% | Details | |
| 12/26/2018 | Acorda Therapeutics, Inc. | ACOR | Maintain | Sell (N/A) |
|
Details | ||
| 12/19/2018 | Cellectis | CLLS | New Coverage | Neutral (N/A) |
17.71 (15.74) |
-11.12% | Details | |
| 12/11/2018 | Acorda Therapeutics, Inc. | ACOR | Downgrade | Sell (Neutral) |
18.63 (0.89) |
-95.22% | Details | |
| 11/5/2018 | Allogene | ALLO | New Coverage | Buy (N/A) |
26.95 (7.67) |
-71.54% | Details | |
| 9/21/2018 | bluebird bio | BLUE | Downgrade | Buy (Conviction Buy) |
141.30 (18.16) |
-87.15% | Details | |
| 9/19/2018 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 8/28/2018 | Ionis Pharmaceuticals | IONS | Maintain | Sell (Sell) |
|
Details |
